Viking Therapeutics Inc. (VKTX) Business News June 25, 2025, 11:03 UTC Viking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program with GLP-1/GIP Agonist VK2735 Full text
There are no comments here yet...